(MENAFN- GlobeNewsWire - Nasdaq) Advanced Drug Delivery Systems (ADDS) offer significant market opportunities by enhancing drug effectiveness and patient compliance across multiple therapeutic fields. Key areas of growth include oncology, cardiology, and neurology, with diverse carriers like nanoparticles and liposomes enabling targeted delivery globally.

Dublin, Aug. 22, 2025 (GLOBE NEWSWIRE) -- The "Advanced Drug Delivery Systems (ADDS) World Market" report has been added to ResearchAndMarkets.com's offering.
Advanced Drug Delivery Systems (ADDS) are specialized technologies designed to modify the release, absorption, distribution, and elimination of therapeutic agents to achieve precise, controlled, or targeted drug delivery, enhancing therapeutic outcomes while minimizing adverse effects. These systems improve drug solubility, bioavailability, and therapeutic effects while reducing side effects and dosing frequency, thus improving patient compliance and health outcomes.

ADDS utilizes various carriers such as nanoparticles, monoclonal antibodies, liposomes, Polymeric Nanoparticles, prodrugs, and microparticles to safeguard and deliver medications to targeted areas within the body. These carriers can be combined with various delivery methods, including oral systems for ease of use, injectable or parenteral methods for rapid drug action, inhalation systems for localized respiratory therapy, and implantable devices for sustained, prolonged release.

Moreover, delivery systems such as transdermal patches, topical applications, ocular and otic delivery, bioadhesive formulations, and hybrid platforms provide customized solutions for distinct clinical requirements.
These adaptive delivery systems have revolutionized treatment approaches across various therapeutic fields, including oncology, cardiology, neurology, pulmonary disorders, ophthalmology, infectious diseases, inflammatory conditions, and chronic illnesses like diabetes and gastrointestinal issues. Notably, lipid-based carriers have played an essential role in facilitating the delivery of mRNA vaccines, while gene delivery systems hold significant potential for treating genetic and rare conditions. As research progresses, ADDS continues to foster innovation, leading to more personalized, targeted, and efficient therapies that are transforming the landscape of contemporary medicine.
This world market compendium analyzes the market for Advanced Drug Delivery Systems at high level by route of administration, vehicle/carrier, application and geographic region. The market is studied for historical/current trends and future forecast in terms of value in US$ for 2021, 2024 and 2030.

This report provides the estimates and forecast for the global Advanced Drug Delivery Systems market. The study also provides the key market developments and a list of major players in this market that are cited.
Key Topics Covered:
1. MARKET SEGMENTATION

• Route of Administration
• Vehicle/Carrier Type
• Application
• Geographic Region

2. WORLD MARKET COMPENDIUM

• Market Demand by Geographic Region
• Market Demand by Route of Administration
• Market Demand by Vehicle/Carrier Type
• Market Demand by Application

3. REGIONAL MARKET COMPENDIUM

• North America
• Europe
• Asia-Pacific
• Rest of World

4. LATEST MARKET DEVELOPMENTS

• Nanoparticles and mAbs Primarily Shaping Parenteral Administration of ADDS
• Multiple Advancements Stimulating Demand for Nanoparticle-Based ADDS
• Integration of Monoclonal Antibodies into ADDS Expediting Demand
• Injectable/Parenteral Route for Drug Delivery Outpaces Oral Administration
• Technological Developments in ADDS Supporting Neurological Applications

5. MAJOR MARKET PLAYERS
Companies Featured

• Abbott Laboratories, Inc.
• Abbvie, Inc.
• Adare Pharmaceuticals, Inc
• Alkermes, Inc.
• Amgen, Inc.
• AptarGroup, Inc.
• AstraZeneca plc
• Baxter International Inc.
• Bayer AG
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Bristol-Myers Squibb Company
• Catalent, Inc.
• Elixir Medical Corporation
• Evonik Industries AG
• F. Hoffmann-La Roche AG
• Gerresheimer AG
• Hisamitsu Pharmaceutical Co., Inc.
• HNS International, Inc.
• Insulet Corporation
• Johnson & Johnson
• Kindeva Drug Delivery L.P.
• Lonza Group AG
• Medtronic plc
• Novartis AG
• Novavax, Inc.
• Pfizer, Inc.
• Recipharm AB
• Serina Therapeutics, Inc.
• SHL Group
• Stevanato Group
• Terumo Corporation
• Teva Pharmaceutical Industries Ltd.
• Vetter Pharma International GmbH
• West Pharmaceutical Services, Inc.
• Ypsomed Holding AG

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN22082025004107003653ID1109962681